Keynote Speakers Time Topic Presenter 1:00pm Opening: GHP website Prof. Dr. Heinz Josef-Schmitt Mainz, Germany 1:05pm COVID Summary (45 mins) Prof. Robert Booy Sydney, Australia 1:50pm Measles Elimination...

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world’s oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with...

Learn more at World Vaccine Day

Over the next 50 years, climate change could drive over 15,000 new cases of mammals transmitting viruses to other mammals, according to a study published in Nature. It’s one of the first to predict how global...

Brazzaville – Africa is witnessing a surge in outbreaks of vaccine-preventable diseases over the past year. Almost 17,500 cases of measles were recorded in the African region between January and March 2022...

Three new observational studies from Scotland, Denmark, and the United States detail reduced hospitalizations and emergency department (ED) visits for Omicron COVID-19 infections relative to those caused by...

Outbreak at a glance: Since the WHO Disease Outbreak News on Acute hepatitis of unknown etiology – the United Kingdom of Great Britain and Northern Ireland was published on 15 April 2022, there have been...

A new study on Chile’s national COVID-19 vaccination program, to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in...

The health authorities of the African nation declared a new outbreak of Ebola after a case was confirmed in Mbandaka, a city in the north-western Equateur Province, the World Health Organization (WHO) reported...

Invasive pneumococcal disease rates have decreased substantially in children and adults since 2010, when use of 13-valent pneumococcal conjugate vaccine in children became the standard of care. Adults 65 years...

A new digital health study by researchers at Scripps Research shows how data from wearable sensors, such as smartwatches and fitness bands, can track a person’s physiological response to the COVID-19...

Monkeys treated with monoclonal antibodies fully recovered, but infection recurred The Ebola virus can hide in the brains of monkeys that have recovered after medical treatment without causing symptoms and...

Public health experts have warned of a possible outbreak of the XE subvariant of the omicron coronavirus variant in Japan, where signs of a potential seventh COVID-19 wave are emerging. The health ministry...

The World Health Organization (WHO) and the EU’s health agency have issued warnings to other countries to be on the alert following a mysterious spike in cases of severe liver disease in children in the UK...

The CDC issued a health warning on April 9, 2022 about an outbreak of meningococcal disease in Florida. Multiple meningococcal disease cases in college students had been reported in the state of Florida over...

Researchers at The University of Adelaide have found that the meningococcal B vaccine could improve protection against gonorrhoea in addition to protection against meningococcal B meningitis. This significant...

A recent study published in Emerging Infectious Diseases discusses a case report of the probable vertical transmission of tick-borne encephalitis virus (TBEV) from an unvaccinated mother to her newborn via...

A new study, led by researchers from the University of California, Irvine, identifies a reason for why older adults are significantly more susceptible to infectious diseases than younger people, a critical...

The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable...

There is no treatment or vaccine for the West Nile, dengue, or Zika viruses. These infections caused by flaviviruses—mosquito-borne viruses—are a major public health concern worldwide. Understanding their...

Indiana University will further develop a new technology for a combination oral rotavirus-norovirus vaccine for infants, thanks to a $1.2 million grant from venture capital firm GIVAX Inc. The technology...

The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s...

The COVID pandemic showed lack of preparedness in many public health areas all over Europe. One such gap – often overlooked – is the lack of tools to rapidly conduct clinical studies on new vaccines...

Behind geopolitical conflicts and the ongoing COVID-19 pandemic are the sporadic chains of avian influenza outbreaks with 79 notifications spread across countries from Africa, Asia, Europe and America within...

The mRNA-based COVID-19 vaccines made by Pfizer/BioNTech and Moderna have proven highly effective at priming our immune systems to fight the pandemic coronavirus—preventing substantial amounts of infection...

Background Most TBE virus infections remain asymptomatic; but when the infection is symptomatic, the disease can manifest with fever and can often involve the central nervous system (CNS) which leads to tick...

Japan’s National Institute of Infectious Diseases (NIID) announced on its website on March 28 that the coronavirus can be transmitted through inhalation of aerosols floating in the air containing the...

Noma is also known as necrotizing ulcerative stomatitis or cancrum oris, a severely debilitating orofacial infection. It has been known for centuries and was already reported by Hippocrates and other...

Researchers have created a test that can predict which dengue patients will likely have mild symptoms and which should be clinically monitored for a high risk of severe illness. Most of the about 390 million...

Influenza, commonly referred to as “flu”, is a major global public health concern and a huge economic burden to societies. Seasonal influenza epidemics afflict between 13 to 100 million individuals annually...

The human body’s T cells provide long-lasting memory against the virus following vaccination or infection from COVID-19, a study led by the Peter Doherty Institute for Infection and Immunity (Doherty...

As COVID-19 case numbers climb in East Asia and now Europe — a surge largely attributed to the BA.2 subvariant of omicron — it makes sense that concern would rise in the U.S. It’s happened before during the...

A Bordetella pertussis outbreak has been reported by the National Institute of Health (INS) of Colombia in the Kogui community, an indigenous group living in the Sierra Nevada de Santa Marta mountains in...

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use. And with minor changes, Northwestern University...

A study has found that much higher doses of antibiotics are needed to eliminate a bacterial infection of the airways when other microbes are present. It helps explain why respiratory infections often persist...

Kenya identified its first case of Covid-19 on 12th March 2020. It has since then undertaken a series of measures to contain the spread and management of the disease in the country. In a population of...

A new model to analyse infectious disease outbreak data has been developed by mathematicians that could be used to improve disease tracking and control. Researchers from the University of Nottingham developed...

Close interactions with infectious disease set both UC Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory...

A 3rd death has been linked to a Mycobacterium chelonae outbreak at Cambridge’s Royal Papworth Hospital, England. A 26-year-old patient underwent a double lung and heart transplant in June 2019. The...

Simulations by UC Riverside-led team could help design nanocontainers used in drug delivery Each simple RNA virus has a genome, its “native RNA.” This genome dictates how the virus replicates in cells to...

The influenza virus caused between 9–41 million illnesses and 12–52,000 deaths in the United States each year between 2010 and 2020. In a “bad” flu year, around 30,000 people die in the UK from flu and...

Australia’s Acting Chief Medical Officer, Dr Sonya Bennett, has declared the unfolding situation in Australia concerning the Japanese encephalitis virus (JEV) a Communicable Disease Incident of National...

A research team led by the Technical University of Munich (TUM) has successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus penetrates the cell. The...

Background During the last 30 years, the number of reported TBE cases in Europe has increased by more than 193%, despite two effective TBE vaccines (FSME Immune and Encepur) being available. The raison for...

The Latin American Society of Pediatric Infectology (SLIPE for its acronym in Spanish) is working hard to strengthen the vaccination recommendations as the most effective method to prevent meningococcal...

The Advisory Committee on Immunization Practices (ACIP) voted on February 23, 2022, to recommend a TBE vaccine for people 12 months of age and older, who are travelling to TBE-endemic areas. TBE is a viral...

A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response. The new research, published in...

The Global Polio Laboratory Network (GPLN) has confirmed the presence of a type 1 wild poliovirus (WPV1) in a child suffering from paralysis in Lilongwe, the capital of Malawi. Analysis shows that the virus is...

Temperature variation affects pathogens and their hosts in distinct ways, and these organisms are influenced by the type of variation and the average background temperature it is applied to. Temperature...

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, along with the continuous transmission of influenza viruses and other coronaviruses, remains a serious global threat to public...

High coverage rates of vaccination against COVID-19 are envisaged to end the pandemic. However, waning of vaccine-induced protection is a growing concern that has been fostered by data on vaccine effectiveness...

Among the G20 goals being pursued by the Indonesian chair this year is ‘ensuring equitable access to COVID-19 vaccines’. This has become a pressing task, though one that’s part of a bigger picture. Developing...

In the long-term battle between a herpesvirus and its human host, a University of Massachusetts Amherst virologist and her team of students have identified some human RNA able to resist the viral takeover –...

Introduction As of January 30, 2022, Cameroon has recorded 1,102 cholera cases across five Regions. The outbreak has already claimed the lives of 32 persons. These figures were reported by the Cameroon...

The Covid-19 pandemic has understandably dominated the news cycle for almost 2 years now. As we hopefully get past the Omicron variant, it’s important not to lose sight of the currently over 7 million...

Two studies to be presented at upcoming professional society meetings suggest that some long COVID-19 symptoms may be related to the effect of SARS-CoV-2 on the vagus nerve and that the use of enhanced...

The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized...

Researchers at the University of Maryland School of Medicine (UMSOM) and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19. The...

At least 74 children have died following an outbreak of measles in Afghanistan’s northern province of Badakhshan, a provincial official said on 6. Feb 2022. Most of the children who lost their lives were...

New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that, although over time the number of SARS-CoV-2...

First steps towards protection from the many and variable viral strains Volunteers in the US recently received the first experimental doses of a new type of HIV vaccine. Using Moderna’s mRNA platform, the...

In 2020–2021, a group of researchers from Gomel State Medical University conducted a prospective comparative clinical research that clearly demonstrates the differences in immunogenicity and reactogenicity of...

Background In Sweden, the number of TBE cases have dramatically increased over the past three decades, with an average of 328 notified cases annually during the past 5 years (2017–2021), which corresponds to...

Findings from the UK’s world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults. The collaborative study is the first in the world to perform...

Like in many countries, Cameroon, a Central African Country, was quick to introduce and roll out COVID-19 vaccines. These introductions were preceded by a recommendation for the National Immunization Technical...

Immunization is a success story for global health and development. It is an intervention that has saved millions of lives every year. Each year, over 116 million infants – 86% of all infants born in that year...

People previously infected with SARS-CoV-2 are substantially protected against COVID-19 for several months, even in the absence of vaccination, a study found. Beyond that, however, their natural immunity wanes...

A Pseudomonas aeruginosa outbreak in Northern Norway was discovered in November 2021. Three patients, admitted for COVID-19, fell seriously ill and died of blood stream infection with identical Pseudomonas...

A Cholera outbreak was detected in Barangay Santiago, Caraga Davao Oriental, the Philippines, on January 31, 2022, affecting 265 residents. The area’s existing water system, in need of rehabilitation, is...

In mid-2021, The Philippines Department of Health announced a 13% increase of Leptospirosis cases compared to the same period in 2020 with a case fatality rate of 11.4%. Global estimates are around 500,000...

An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers...

In adults who had previously received a full regimen of a COVID-19 vaccine approved or authorized by the Food and Drug Administration (FDA), an additional dose of any of these COVID-19 vaccines was safe and...

A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies, according to a new study in the journal npj Vaccines. The research is a...

In January 2022, a cluster of around 30 people were hospitalized due to typhoid fever in Manaulanan village, North Cotabato, The Philippines. The village does not have access to potable water. In response to...

Despite the goal of becoming rabies free by 2022, 12 deaths due to rabies were reported in 2021 in the province of Iloilo, The Philippines, a 3-fold increase from 2020. Five of the 6 towns/cities from where...

In July 2021, the Head of Provincial Health Division reported a record of 61 deaths in one week due to a disease presenting with symptoms of bacterial meningitis, i.e., fever, vomiting, loss of consciousness...

Get ready to learn more Greek letters. Scientists warn that omicron’s whirlwind advance practically ensures it won’t be the last version of the coronavirus to worry the world. Every infection provides a chance...

A recent study used surveillance data for the entire population of North Carolina to evaluate the durability of protection provided by the Pfizer, Moderna, and Johnson & Johnson vaccines. This large...

Omicron is very good at evading the immune protection conferred by vaccines, natural infection and agents such as monoclonal antibodies (mAbs) authorized to prevent serious infections, according to David Ho...

A World Health Organization (WHO) advisory group set up in September to examine the impact of SARS-CoV-2 variants on vaccine performance laid out a framework for assessing updated versions of COVID-19...

Acceptance of a combination influenza-COVID-19 vaccine among minority individuals is higher than for the COVID-19 vaccine alone, according to new research led by Penn State. The results suggest that bundling...

Scientists have long linked the virus that causes mono to MS. Evidence is mounting that a garden-variety virus that sometimes causes mono in teens is the underlying cause of multiple sclerosis, a rare...

The effectiveness of face masks has been a hotly debated topic since the emergence of COVID-19. However, a new study by researchers at the University of Central Florida offers more evidence that they work. In...

A Singapore team of researchers is working on the next generation of mRNA vaccines that could have doses up to 100 times smaller than current ones and be cheaper to manufacture. Some of the production...

Experts from Imperial College London and Singapore’s Lee Kong Chian School of Medicine (LKCMedicine) and National Centre for Infectious Diseases (NCID) met virtually in December to discuss their findings from...

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial...

Good timing is a key to success — even for riding out the Omicron wave. Research from Japan suggests that COVID-19 vaccination followed months later by a breakthrough SARS-CoV-2 infection offers greater...

COVID-19 vaccination is approved for children 5 years and older, but younger children and babies are also susceptible to infection. A recent study, published in the Obstetrics & Gynecology journal, found...

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge – but preliminary evidence suggests it is...

COVID-19 vaccination provides a foundation of protection that’s enhanced by breakthrough infection; ‘the key is to get vaccinated’ Breakthrough infections greatly enhance immune response to variants of the...

A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs and potentially emerge to...

An international team have mapped how the HTLV-1 virus causes a rare leukaemia in some people, providing clues on how to stop it happening. The team, led by Imperial College London and Kumamoto University in...

Zoonotic diseases—caused by germs that spread between animals and people—are common. According to the Centers for Disease Control and Prevention, three of every four new or emerging infectious diseases in...

A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found. The combination includes...

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National...

In quickly moving scientific developments over the past 24 hours, three separate labs that tested the Omicron (B.1.1.529) COVID-19 variant against vaccines reported significant immune escape based on reduced...

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant — a compound that stimulates the immune system to produce a stronger response. Researchers from MIT, the La Jolla...

About a year passed between COVID-19’s discovery and the creation of a vaccine. Why was malaria so much harder? The World Health Organization (WHO) recommended a broad rollout for a malaria vaccine after...

A top Pfizer executive says the company is hopeful that booster shots will provide sufficient protection against the Omicron variant — but has already envisioned a timeline for the development of a new vaccine...